Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL.
Picardi M, Della Pepa R, Giordano C, Zacheo I, Pugliese N, Mortaruolo C, Trastulli F, Giordano A, Lucignano M, Di Perna M, Raimondo M, Salvatore C, Pane F. Picardi M, et al. Among authors: di perna m. Blood. 2019 Jan 31;133(5):498-501. doi: 10.1182/blood-2018-10-878892. Epub 2018 Dec 7. Blood. 2019. PMID: 30530802 Free PMC article. No abstract available.
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone.
Cerchione C, Catalano L, Peluso I, Nappi D, Di Perna M, Salvatore D, Migliaccio I, Picardi M, Pane F. Cerchione C, et al. Among authors: di perna m. Support Care Cancer. 2016 Dec;24(12):4835-4837. doi: 10.1007/s00520-016-3430-9. Epub 2016 Oct 10. Support Care Cancer. 2016. PMID: 27726031 Free PMC article. No abstract available.
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience.
Cerchione C, De Renzo A, Di Perna M, Della Pepa R, Pugliese N, Catalano L, Pane F, Picardi M. Cerchione C, et al. Among authors: di perna m. Support Care Cancer. 2017 Mar;25(3):839-845. doi: 10.1007/s00520-016-3468-8. Epub 2016 Nov 3. Support Care Cancer. 2017. PMID: 27812763 Free PMC article.
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma.
Pugliese N, Di Perna M, Cozzolino I, Ciancia G, Pettinato G, Zeppa P, Varone V, Masone S, Cerchione C, Della Pepa R, Simeone L, Giordano C, Martinelli V, Salvatore C, Pane F, Picardi M. Pugliese N, et al. Among authors: di perna m. Ann Hematol. 2017 Apr;96(4):627-637. doi: 10.1007/s00277-017-2926-9. Epub 2017 Jan 27. Ann Hematol. 2017. PMID: 28130574 Free PMC article. Clinical Trial.
Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma.
Della Pepa R, Picardi M, Giordano C, Zacheo I, Pugliese N, Cerchione C, Raimondo M, Di Perna M, Troncone G, Ciancia G, Intrieri M, Pane F. Della Pepa R, et al. Among authors: di perna m. Br J Haematol. 2018 Sep;182(5):715-718. doi: 10.1111/bjh.14856. Epub 2017 Jul 24. Br J Haematol. 2018. PMID: 28737231 Free article. No abstract available.
Safety and comfort of domestic bortezomib injection in real-life experience.
Cerchione C, Nappi D, Pareto AE, Di Perna M, Zacheo I, Picardi M, Pane F, Catalano L. Cerchione C, et al. Among authors: di perna m. Support Care Cancer. 2018 Sep;26(9):3111-3116. doi: 10.1007/s00520-018-4155-8. Epub 2018 Mar 24. Support Care Cancer. 2018. PMID: 29574618
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience.
Iula R, De Novellis D, Trastulli F, Della Pepa R, Fontana R, Carobene A, Di Perna M, D'Ambrosio A, Romano M, Leone A, De Fazio L, Fiumarella A, Gaeta G, Marafioti V, Barbato S, Palmieri S, Rocco S, Serio B, Califano C, Pane F, Ferrara F, Giudice V, Selleri C, Catalano L. Iula R, et al. Among authors: di perna m. Front Oncol. 2022 Nov 15;12:1026251. doi: 10.3389/fonc.2022.1026251. eCollection 2022. Front Oncol. 2022. PMID: 36457484 Free PMC article.
60 results